Prometheus Biosciences, Inc. carries a market capitalization of 9.56B, placing it among publicly traded companies globally.
| Market Cap | 9.56B |
| Enterprise Value | N/A |
Prometheus Biosciences, Inc.'s stock has gained approximately 576.54822% over the past 52 weeks. The 50-day moving average sits at 182.36, while the 200-day moving average is 108.85.
| Beta (5Y) | N/A |
| 52-Week Price Change | 576.54822% |
| 50-Day Moving Average | 182.36 |
| 200-Day Moving Average | 108.85 |
| Average Volume (20 Days) | N/A |